1
|
Yun S, Oh J, Chu H, Park D, Leem J. Systematic Review of Preclinical Studies on the Efficacy and Mechanisms of Herbal Medicines in Post-Myocardial Infarction Heart Failure with Reduced Ejection Fraction. MEDICINA (KAUNAS, LITHUANIA) 2024; 60:1101. [PMID: 39064530 PMCID: PMC11278938 DOI: 10.3390/medicina60071101] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/12/2024] [Revised: 07/01/2024] [Accepted: 07/03/2024] [Indexed: 07/28/2024]
Abstract
Background and Objectives: Heart failure with reduced ejection fraction (HFrEF) remains a significant burden. Traditional herbal medicines have shown cardioprotective effects in treating HFrEF. However, the implications of herbal formulation considering the dynamic immunohistological changes in the myocardium following acute ischemic injury have been insufficiently discussed. This review investigated the efficacy and mechanisms reported in studies using rat or mouse models of HFrEF induced by left descending coronary artery ligation. Materials and Methods: A systematic search was conducted using PubMed, Embase, AMED, CINAHL, and CENTRAL databases. Information was extracted regarding study characteristics, disease model induction protocols, intervention characteristics, treatment protocols, outcomes, and suggested mechanisms. Hierarchical cluster analysis of test drugs was performed based on constituent herb similarities. The risk of bias (RoB) was assessed using the Systematic Review Center for Laboratory animal Experimentation RoB tool. Results: Overall, 26 studies met the eligibility criteria. HF model induction periods after LADCA ligation ranged from 1 day to 12 weeks. Most studies administered the test drug for four weeks. Commonly used herbs included Panax ginseng, Astragalus membranaceus, Salvia miltiorrhiza, Carthamus tinctorius, and Lepidium apetalum, which demonstrated anti-fibrotic, anti-inflammatory, and anti-apoptotic effects through various signaling pathways. The overall RoB was relatively high. No significant association was found between model induction periods and herbal formulations or examined mechanisms. Conclusions: Future research should consider the time-dependent immunohistological features of the myocardium during HF treatment.
Collapse
Affiliation(s)
- Soyeong Yun
- Department of Obstetrics & Gynecology of Korean Medicine, Wonkwang University Jeonju Korean Medicine Hospital, 99 Garyeonsan-ro, Deokjin-gu, Jeonju 54887, Jeollabuk-do, Republic of Korea;
| | - Jieun Oh
- Department of Neuropsychiatry of Korean Medicine, Wonkwang University Jeonju Korean Medicine Hospital, 99 Garyeonsan-ro, Deokjin-gu, Jeonju 54887, Jeollabuk-do, Republic of Korea;
| | - Hongmin Chu
- Department of Internal Medicine and Neuroscience, College of Korean Medicine, Wonkwang University, 460 Iksan-daero, Sin-dong, Iksan 54538, Jeollabuk-do, Republic of Korea;
| | - Dasol Park
- Department of Diagnostics, College of Korean Medicine, Wonkwang University, 460 Iksan-daero, Sin-dong, Iksan 54538, Jeollabuk-do, Republic of Korea
| | - Jungtae Leem
- Department of Diagnostics, College of Korean Medicine, Wonkwang University, 460 Iksan-daero, Sin-dong, Iksan 54538, Jeollabuk-do, Republic of Korea
- Research Center of Traditional Korean Medicine, College of Korean Medicine, Wonkwang University, 460 Iksan-daero, Sin-dong, Iksan 54538, Jeollabuk-do, Republic of Korea
- Korean Medicine Clinical Research Institute, Wonkwang University Korean Medicine Hospital, 895 Muwang-ro, Iksan 54538, Jeollabuk-do, Republic of Korea
| |
Collapse
|
2
|
Yan H, Zhu Y, Jia H, Li Y, Han Y, Zheng X, Yue X, Zhao L, Feng W. A chromosome-level genome assembly and annotation of the medicinal plant Lepidium apetalum. BMC Genom Data 2024; 25:61. [PMID: 38886663 PMCID: PMC11184738 DOI: 10.1186/s12863-024-01243-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2024] [Accepted: 06/12/2024] [Indexed: 06/20/2024] Open
Abstract
OBJECTIVES As a traditional Chinese medicine, Lepidium apetalum is commonly used for purging the lung, relieving dyspnea, alleviating edema, and has the significant pharmacological effects on cardiovascular disease, hyperlipidemia, etc. In addition, the seeds of L. apetalum are rich in unsaturated fatty acids, sterols, glucosinolates and have a variety of biological activity compounds. To facilitate genomics, phylogenetic and secondary metabolite biosynthesis studies of L. apetalum, we assembled the high-resolution genome of L. apetalum. DATA DESCRIPTION We completed chromosome-level genome assembly of the L. apetalum genome (2n = 32), using Illumina HiSeq and PacBio Sequel sequencing platform as well as high-throughput chromosome conformation capture (Hi-C) technique. The assembled genome was 296.80 Mb in size, 34.41% in GC content, and 23.89% in repeated sequence content, including 316 contigs with a contig N50 of 16.31 Mb. Hi-C scaffolding resulted in 16 chromosomes occupying 99.79% of the assembled genome sequences. A total of 46 584 genes and 105 pseudogenes were predicted, 98.37% of which can be annotated to Nr, GO, KEGG, TrEMBL, SwissPort, Pfam and KOG databases. The high-quality reference genome generated by this study will provide accurate genetic information for the molecular biology research of L. apetalum.
Collapse
Affiliation(s)
- Hang Yan
- School of Pharmacy, Henan University of Chinese Medicine, No. 156 Jinshui East Road, Zhengzhou, Henan, 450046, China
| | - Yunhao Zhu
- School of Pharmacy, Henan University of Chinese Medicine, No. 156 Jinshui East Road, Zhengzhou, Henan, 450046, China
- The Engineering and Technology Research Center for Chinese Medicine Development of Henan Province, Zhengzhou, 450046, China
| | - Haoyu Jia
- School of Pharmacy, Henan University of Chinese Medicine, No. 156 Jinshui East Road, Zhengzhou, Henan, 450046, China
- The Engineering and Technology Research Center for Chinese Medicine Development of Henan Province, Zhengzhou, 450046, China
| | - Yuanjun Li
- School of Pharmacy, Henan University of Chinese Medicine, No. 156 Jinshui East Road, Zhengzhou, Henan, 450046, China
- The Engineering and Technology Research Center for Chinese Medicine Development of Henan Province, Zhengzhou, 450046, China
| | - Yongguang Han
- School of Pharmacy, Henan University of Chinese Medicine, No. 156 Jinshui East Road, Zhengzhou, Henan, 450046, China
| | - Xiaoke Zheng
- School of Pharmacy, Henan University of Chinese Medicine, No. 156 Jinshui East Road, Zhengzhou, Henan, 450046, China
- The Engineering and Technology Research Center for Chinese Medicine Development of Henan Province, Zhengzhou, 450046, China
| | - Xiule Yue
- Ministry of Education Key Laboratory of Cell Activities and Stress Adaptations, School of Life Sciences, Lanzhou University, No. 222 Tianshui South Road, Lanzhou, Gansu, 730000, China.
| | - Le Zhao
- School of Pharmacy, Henan University of Chinese Medicine, No. 156 Jinshui East Road, Zhengzhou, Henan, 450046, China.
- The Engineering and Technology Research Center for Chinese Medicine Development of Henan Province, Zhengzhou, 450046, China.
| | - Weisheng Feng
- School of Pharmacy, Henan University of Chinese Medicine, No. 156 Jinshui East Road, Zhengzhou, Henan, 450046, China.
- The Engineering and Technology Research Center for Chinese Medicine Development of Henan Province, Zhengzhou, 450046, China.
| |
Collapse
|
3
|
Wang J, Liu Y, Guo Y, Liu C, Yang Y, Fan X, Yang H, Liu Y, Ma T. Function and inhibition of P38 MAP kinase signaling: Targeting multiple inflammation diseases. Biochem Pharmacol 2024; 220:115973. [PMID: 38103797 DOI: 10.1016/j.bcp.2023.115973] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2023] [Revised: 12/02/2023] [Accepted: 12/05/2023] [Indexed: 12/19/2023]
Abstract
Inflammation is a natural host defense mechanism that protects the body from pathogenic microorganisms. A growing body of research suggests that inflammation is a key factor in triggering other diseases (lung injury, rheumatoid arthritis, etc.). However, there is no consensus on the complex mechanism of inflammatory response, which may include enzyme activation, mediator release, and tissue repair. In recent years, p38 MAPK, a member of the MAPKs family, has attracted much attention as a central target for the treatment of inflammatory diseases. However, many p38 MAPK inhibitors attempting to obtain marketing approval have failed at the clinical trial stage due to selectivity and/or toxicity issues. In this paper, we discuss the mechanism of p38 MAPK in regulating inflammatory response and its key role in major inflammatory diseases and summarize the synthetic or natural products targeting p38 MAPK to improve the inflammatory response in the last five years, which will provide ideas for the development of novel clinical anti-inflammatory drugs based on p38 MAPK inhibitors.
Collapse
Affiliation(s)
- Jiahui Wang
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China
| | - Yongjian Liu
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China
| | - Yushi Guo
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China
| | - Cen Liu
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China
| | - Yuping Yang
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China
| | - Xiaoxiao Fan
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China
| | - Hongliu Yang
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China
| | - Yonggang Liu
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
| | - Tao Ma
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
| |
Collapse
|